WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> US Rejoining COVAX Should Involve More Resources, Says Fauci 05/02/2021 Kerry Cullinan The US decision to join COVAX “is likely to mean resources” to be able to get vaccines for people, Dr Tony Fauci, US President Joe Biden’s Chief Medical Advisor, told the International AIDS Society’s COVID-19 conference this week. Fauci also told the conference that scientists were taking the SARS-COV2 variant identified in South Africa so […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Rejoining COVAX Should Involve More Resources, Says Fauci 05/02/2021 Kerry Cullinan The US decision to join COVAX “is likely to mean resources” to be able to get vaccines for people, Dr Tony Fauci, US President Joe Biden’s Chief Medical Advisor, told the International AIDS Society’s COVID-19 conference this week. Fauci also told the conference that scientists were taking the SARS-COV2 variant identified in South Africa so […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts